Sameh Daher
Haifa, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.
Journal: JCO precision oncology
Published: March 30, 2026
Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort.
Journal: Frontiers in oncology
Published: March 02, 2026
Brief Report: Intestinal Lymphangiectasia With Selpercatinib and Pralsetinib Treatment.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 10, 2025
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study.
Journal: JTO clinical and research reports
Published: October 23, 2025
Correlation of PET-CT, Endobronchial Ultrasound Cytology and Surgical Biopsy in Patients with Non-Small Cell Lung Cancer Undergoing Curative Surgery.
Journal: Clinical lung cancer
Published: February 28, 2025
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 25, 2025
Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer.
Journal: Journal of clinical medicine
Published: September 28, 2024
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study).
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2024
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery.
Journal: The British journal of radiology
Published: September 26, 2023
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 16, 2022
Last Updated: 09/26/2026